Drug Trial Radar · NCT05970510
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
555
Actual
Start
Aug 4, 2023
Primary completion
Jul 31, 2025
Study completion Jul 31, 2025
Sponsor
- Lead sponsor
- Luye Pharma Group Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to evaluate the efficacy and safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets compared to placebo in adults participants with generalized anxiety disorder over a period of 8 weeks.
Conditions
- Generalized Anxiety Disorder
Interventions
Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mgDrug
orally once a day
Toludesvenlafaxine Hydrochloride Sustained-release Tablet 160mgDrug
orally once a day
placeboDrug
orally once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the Hamilton Anxiety(HAMA) Rating Scale total score at endpointTime frame: from baseline to week 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University Sixth Hospital
Beijing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.